from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3557c/-

LFCtreatmentdescriptionclass of inhibitor

0.470

Amikacinug/mL Amikacintranslation

1.024

Cap5-10ug/mL Capreomycintranslation

1.988

Rox10-50 ug/mL Roxithromycintranslation

-0.103

SM2-5 ug/mL Streptomycintranslation

0.315

Tet5-10 ug/mL Tetracyclinetranslation

0.155

Rif0.2-5ug/mL Rifampicintranscription

0.333

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.024

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.589

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.360

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.675

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.371

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.836

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.941

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.860

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.513

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.850

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.748

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.311

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.402

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.889

KCN5-20 ug/mL Potassium cyaniderespiration

-1.037

NaN30.2-2 mM Sodium aziderespiration

0.086

Nigericin50 uM Nigericinrespiration

-0.043

TRC10-150 ug/mL Triclosanrespiration

0.096

TRZ10-25 ug/mL Thioridazinerespiration

1.477

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.048

menadione6-10 ug/mL Menadionerespiration

2.009

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.182

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.250

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.261

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.363

NRP_1Non-replicating persistence stage 1dosRassociated

-0.347

Amp0.2mg/mL AmpicillincellWall

-0.357

Cephalexin20-100 ug/mL CephalexincellWall

0.281

Cerulenin0.32-5 ug/mL CerulenincellWall

1.138

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.546

EMB10-20 ug/mL EthambutolcellWall

0.906

Eta12-40 ug/mL EthionamidecellWall

0.343

INH0.2-0.4 ug/mL IsoniazidcellWall

0.142

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.396

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.042

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.003

BZA0.12 mg/mL BenzamidearomaticAmides

0.157

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.096

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.248

H2O24 mM hydrogen peroxideDNAdamaging

-0.169

Levo10 ug/mL LevofloxacinDNAdamaging

0.114

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.735

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.218

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.167

UVUV-irradiationDNAdamaging

-0.878

ARP41-4 ug/mL Antitubercular compound ARP4?

0.008

Antimycin12.5-50 ug/mL Antimycin A?

-0.125

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.688

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.744

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.075

PA8240.2-2 ug/mL PA-824?

-0.116

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.390

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.025

Verapamil50 uM Verapamil?

-0.189

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.244

methoxatin10-20 ug/mL Methoxatin?